Kampf Julie B. 4

What Happened
Julie B. Kampf, a director of Jupiter Neurosciences, was granted 100,000 derivative securities (options/awards) on June 2, 2026. The reported acquisition price is $0.00 (transaction code A), so no cash was paid; the reported value of the grant in the filing is $0.

Key Details

• Transaction date: 2026-06-02; Filing date: 2026-06-04 (timely filing).
• Transaction type/code: A (award/grant of a derivative security). Reported price: $0.00; reported value: $0.
• Shares/options granted: 100,000 (derivative).
• Shares/securities owned after transaction: not specified in the provided filing excerpt.
• Footnote: The options were granted under the Issuer's 2025 Equity Incentive Plan and vest over three years beginning September 2, 2026, in equal quarterly installments, subject to continued service through each vesting date.

Context
This was an equity award (options) to a board member, not a purchase or sale of shares and not an exercise of options. Such director grants are a common form of compensation and do not by themselves indicate immediate buying or selling of stock. The options do not begin vesting until Sept 2, 2026, so they are subject to future service-based vesting before they can be exercised.